Evaluating complementary and alternative therapies for cancer patients

Area of Science:

• Integrative Oncology
• Evidence-Based Medicine
• Herbal Medicine Research

Background:

• "Complementary and alternative" therapies represent a diverse group of interventions.
• These range from supportive care modalities to unproven cancer treatments.
• Lack of regulation poses risks to consumers seeking unverified remedies.

Purpose of the Study:

• To differentiate between beneficial and harmful complementary and alternative therapies.
• To highlight the importance of evidence-based supportive care in cancer treatment.
• To inform about potential risks associated with unproven remedies and herb-drug interactions.

Main Methods:

• Literature review and analysis of existing research on complementary and alternative therapies.
• Examination of documented benefits of supportive care modalities.
• Assessment of risks, including harmful ingredients and herb-drug interactions.

Main Results:

• Supportive complementary therapies like massage and meditation can enhance well-being during cancer treatment.
• Some herbal remedies show promise for remission induction but require further investigation.
• Many unproven remedies lack regulatory oversight and can contain harmful ingredients.
• Significant risks exist, including herb-drug interactions with anesthetics, anticoagulants, and chemotherapy.

Conclusions:

• Evidence-based complementary therapies should be integrated to improve patient quality of life.
• Patients must be discerning about unproven remedies due to potential harm and lack of efficacy.
• Awareness of herb-drug interactions is crucial for patient safety throughout cancer care.